Anti-Mullerian hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles

Human Fertility

Volumn 14, Issue 4, 2011, Pages 246-253

  Tolikas, A ^a,b   Tsakos, E ^a   Gerou, S ^c   Prapas, Y ^b   Loufopoulos, A ^b  

^a Gynaecology and Fertility Centre   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Laboratories Analysis   (Greece)

Author keywords

Anti Mullerian hormone IVF; Follicle count; Outcome follicular fluid antral

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN TISSUE; INTRACYTOPLASMIC SPERM INJECTION; OVARIAN RESERVE; OVARY; OVARY FOLLICLE FLUID; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTI-MULLERIAN HORMONE; AREA UNDER CURVE; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; HUMANS; MIDDLE AGED; OVARIAN FOLLICLE; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSPECTIVE STUDIES;

EID: 81855161512     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647273.2011.608464     Document Type: Article

References (43)

1. Andersen, C. Y., & Byskov, A. G.2006). Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: Analysis of small antral and preovulatory human follicles' fluid. The Journal of clinical endocrinology and metabolism, 91, 4064-4069. (Pubitemid 44536886)
2. Baczkowski, T., Kurzawa, R., & Glabowski, W.2004). Methods of embryo scoring in in vitro fertilization. Reproductive biology, 4, 5-22.
3. Bancsi, L. F., Broekmans, F. J., Looman, C. W., Habbema, J. D., & te Velde, E. R.2004a). Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertility and sterility, 81, 35-41. (Pubitemid 38058325)
4. Bancsi, L. F., Broekmans, F. J., Looman, C. W., Habbema, J. D., & te Velde, E. R.2004b). Predicting poor ovarian response in IVF: Use of repeat basal FSH measurement. The Journal of reproductive medicine, 49, 187-194. (Pubitemid 38405783)
5. Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B.2006). A systematic review of tests predicting ovarian reserve and IVF outcome. Human reproduction update, 12, 685-718. (Pubitemid 44605509)
6. Broekmans, F. J., de Ziegler, D., Howles, C. M., Gougeon, A., Trew, G., & Olivennes, F.2010). The antral follicle count: Practical recommendations for better standardization. Fertility and sterility, 94, 1044-1051.
7. Broer, S. L., Mol, B. W., Hendriks, D., & Broekmans, F. J.2009). The role of antimullerian hormone in prediction of outcome after IVF: Comparison with the antral follicle count. Fertility and sterility, 91, 705-714.
8. De Vet, A., Laven, J. S., de Jong, F. H., Themmen, A. P., & Fauser, B. C.2002). Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertility and sterility, 77, 357-362. (Pubitemid 34083560)
9. Donahoe, P. K., Clarke, T., Teixeira, J., Maheswaran, S., & MacLaughlin, D. T.2003). Enhanced purification and production of Mullerian inhibiting substance for therapeutic applications. Molecular and cellular endocrinology, 211, 37-42.
10. Durlinger, A. L., Gruijters, M. J., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., et al.2002). Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology, 143, 1076-1084. (Pubitemid 34164056)
11. Durlinger, A. L., Gruijters, M. J., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., et al.2001). Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology, 142, 4891-4899. (Pubitemid 33022365)
12. Durmusoglu, F., Elter, K., Yoruk, P., & Erenus, M.2004). Combining cycle day seven follicle count with the basal antral follicle count improves the prediction of ovarian response. Fertility and sterility, 81, 1073-1078. (Pubitemid 38452976)
13. Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier- Lechner, E., & Tews, G.2006). Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles. Human reproduction (Oxford, England), 21, 2022-2026. (Pubitemid 44288076)
14. Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., et al.2005a). Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human reproduction (Oxford, England), 20,3178-3183. (Pubitemid 41662675)
15. Fanchin, R., Schonauer, L. M., Righini, C., Guibourdenche, J., Frydman, R., & Taieb, J.2003b). Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Human reproduction (Oxford, England), 18, 323-327. (Pubitemid 36236265)
16. Fanchin, R., Mendez Lozano, D. H., Frydman, N., Gougeon, A., di Clemente, N., Frydman, R., et al.2007). Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. The Journal of clinical endocrinology and metabolism, 92, 1796-1802. (Pubitemid 46997191)
17. Ficicioglu, C., Kutlu, T., Baglam, E., & Bakacak, Z.2006). Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertility and sterility, 85, 592-596. (Pubitemid 43261548)
18. Frattarelli, J. L., Levi, A. J., Miller, B. T., & Segars, J. H.2003). A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertility and sterility, 80, 350-355. (Pubitemid 36959793)
19. Hansen, K. R., Morris, J. L., Thyer, A. C., & Soules, M. R.2003). Reproductive aging and variability in the ovarian antral follicle count: Application in the clinical setting. Fertility and sterility, 80, 577-583. (Pubitemid 37102869)
20. Hehenkamp, W. J., Looman, C. W., Themmen, A. P., de Jong, F. H., Te Velde, E. R., & Broekmans, F. J.2006). Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. The Journal of clinical endocrinology and metabolism, 91, 4057-4063. (Pubitemid 44536885)
21. Josso, N., Cate, R. L., Picard, J. Y., Vigier, B., di Clemente, N., Wilson, C., et al.1993). Anti-mullerian hormone: The jost factor. Recent progress in hormone research, 48, 1-59.
22. Kevenaar, M. E., Themmen, A. P., Laven, J. S., Sonntag, B., Fong, S. L., Uitterlinden, A. G., et al.2007). Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normoovulatory women. Human reproduction (Oxford, England), 22, 1547-1554. (Pubitemid 47055141)
23. Kwee, J., Schats, R., McDonnell, J., Themmen, A., de Jong, F., & Lambalk, C.2008). Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertility and sterility, 90, 737-743.
24. La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., & Macklon, N. S.; ESHRE Special Interest Group for Reproductive Endocrinology-AMH Round Table.2009). Anti-Mullerian hormone (AMH): What do we still need to know? Human reproduction (Oxford, England), 24, 2264-2275.
25. La Marca, A., De Leo, V., Giulini, S., Orvieto, R., Malmusi, S., Giannella, L., et al.2005b). Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. Journal of the Society for Gynecologic Investigation, 12, 545-548. (Pubitemid 41395245)
26. La Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., et al.2007). Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Human reproduction (Oxford, England), 22, 766-771.
27. La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A.2006b). Serum anti-Mullerian hormone throughout the human menstrual cycle. Human reproduction (Oxford, England), 21, 3103-3107. (Pubitemid 44811610)
28. Lee, M. M., Donahoe, P. K., Hasegawa, T., Silverman, B., Crist, G. B., Best, S., et al.1996). Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood. The Journal of clinical endocrinology and metabolism, 81, 571-576. (Pubitemid 26055665)
29. Lee, M. M., & Donahoe, P. K.1993). Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocrine reviews, 14, 152-164. (Pubitemid 23118414)
30. Lee, T. H., Liu, C. H., Huang, C. C., Wu, Y. L., Shih, Y. T., Ho, H. N., et al.2008). Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Human reproduction (Oxford, England), 23, 160-167.
31. Maheshwari, A., Fowler, P., & Bhattacharya, S.2006). Assessment of ovarian reserve-should we perform tests of ovarian reserve routinely? Human reproduction (Oxford, England), 21, 2729-2735. (Pubitemid 44566980)
32. Nakhuda, G. S., Chu, M. C., Wang, J. G., Sauer, M. V., & Lobo, R. A.2006). Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization. Fertility and sterility, 85, 1541-1543.
33. Nelson, S. M., Yates, R. W., & Fleming, R.2007). Serum anti- Mullerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy. Human reproduction (Oxford, England), 22, 2414-2421. (Pubitemid 47289055)
34. Penarrubia, J., Fabregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., et al.2005). Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Human reproduction (Oxford, England), 20, 915-922. (Pubitemid 40667835)
35. Scott, R. T., Jr, Hofmann, G. E., Oehninger, S., & Muasher, S. J.1990). Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertility and sterility, 54, 297-302. (Pubitemid 20256240)
36. Seifer, D. B., & Maclaughlin, D. T.2007). Mullerian Inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertility and sterility, 88, 539-546. (Pubitemid 47368260)
37. Smeenk, J. M., Sweep, F. C., Zielhuis, G. A., Kremer, J. A., Thomas, C. M., & Braat, D. D.2007). Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertility and sterility, 87, 223-226. (Pubitemid 46013883)
38. Streuli, I., Fraisse, T., Pillet, C., Ibecheole, V., Bischof, P., & de Ziegler, D.2008). Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertility and sterility, 90, 395-400.
39. Tremellen, K. P., Kolo, M., Gilmore, A., & Lekamge, D. N.2005). Anti-mullerian hormone as a marker of ovarian reserve. The Australian & New Zealand journal of obstetrics & gynaecology, 45, 20-24. (Pubitemid 40424710)
40. Tsepelidis, S., Devreker, F., Demeestere, I., Flahaut, A., Gervy, C. h., & Englert, Y.2007). Stable serum levels of anti-Mullerian hormone during the menstrual cycle: A prospective study in normo-ovulatory women. Human reproduction (Oxford, England), 22, 1837-1840. (Pubitemid 47062749)
41. Van Rooij, I. A., Broekmans, F. J., te Velde, E. R., Fauser, B. C., Bancsi, L. F., de Jong, F. H., et al.2002). Serum anti-Mullerian hormone levels: A novel measure of ovarian reserve. Human reproduction (Oxford, England), 17, 3065-3071. (Pubitemid 35469254)
42. Van Rooij, I. A., Tonkelaar, I., Broekmans, F. J., Looman, C. W., Scheffer, G. J., de Jong, F. H., et al.2004). Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause (New York, N.Y.), 11(6 Pt 1), 601-606. (Pubitemid 40353222)
43. Visser, J. A., Durlinger, A. L., Peters, I. J., van den Heuvel, E. R., Rose, U. M., Kramer, P., et al.2007). Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice. Endocrinology, 148, 2301-2308. (Pubitemid 46997082)